Specify a stock or a cryptocurrency in the search bar to get a summary
Bachem Holding AG
BCHMYBachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland. Address: Hauptstrasse 144, Bubendorf, Switzerland, 4416
Analytics
WallStreet Target Price
65.29 CHFP/E ratio
49.7697Dividend Yield
1.06 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures BCHMY
Dividend Analytics BCHMY
Dividend growth over 5 years
-31 %Continuous growth
4 yearsPayout Ratio 5 years average
33 %Dividend History BCHMY
Stock Valuation BCHMY
Financials BCHMY
Results | 2019 | Dynamics |